ViiV Healthcare ( ) is a British multinational pharmaceutical company specializing in the research and development of medicines to treat and prevent

HIV/AIDS The HIV, human immunodeficiency virus (HIV) is a retrovirus that attacks the immune system. Without treatment, it can lead to a spectrum of conditions including acquired immunodeficiency syndrome (AIDS). It is a Preventive healthcare, pr ...

. Its global headquarters is located in

London London is the Capital city, capital and List of urban areas in the United Kingdom, largest city of both England and the United Kingdom, with a population of in . London metropolitan area, Its wider metropolitan area is the largest in Wester ...

. The company was created as a joint venture by GSK and

Pfizer Pfizer Inc. ( ) is an American Multinational corporation, multinational Pharmaceutical industry, pharmaceutical and biotechnology corporation headquartered at The Spiral (New York City), The Spiral in Manhattan, New York City. Founded in 184 ...

in November 2009, with both companies transferring their HIV assets to the new company.Jacks, Andre
"GSK and Pfizer to Merge HIV Portfolios
Financial Times. 16 April 2010 In 2012, Shionogi joined the company. As of December 2023, 76.5% of the company is owned by GSK, 13.5% by Pfizer and 10% by Shionogi. According to The Financial Times, the company's co-ownership structure may change depending on the achievement of certain milestones. ViiV Healthcare's products have a market share of approximately 32% of the global HIV therapy market, making it the second-largest healthcare company in the sector, after

Gilead Sciences Gilead Sciences, Inc. () is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and CO ...

. ViiV Healthcare's global headquarters are in

in the

United Kingdom The United Kingdom of Great Britain and Northern Ireland, commonly known as the United Kingdom (UK) or Britain, is a country in Northwestern Europe, off the coast of European mainland, the continental mainland. It comprises England, Scotlan ...

, and the company has sites in a number of other countries including the United States, Australia, Belgium, Canada, France, Germany, Italy, Japan, Mexico, the Netherlands, Portugal, Puerto Rico, Russia, Spain and Switzerland.

Products

The company markets 17 products: * Nucleoside reverse transcriptase inhibitors (NRTIs): **

abacavir Abacavir, sold under the brand name Ziagen among others, is a medication used to treat HIV/AIDS. Similar to other nucleoside analog reverse-transcriptase inhibitors (NRTIs), abacavir is used together with other HIV medications, and is not re ...

(brand name Ziagen) **

lamivudine Lamivudine, commonly called 3TC, is an antiretroviral medication used to prevent and treat HIV/AIDS. It is also used to treat chronic hepatitis B when other options are not possible. It is effective against both HIV-1 and HIV-2. It is typi ...

(brand names Epivir and 3TC) **

zidovudine Zidovudine (ZDV), also known as azidothymidine (AZT), was the first antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use in combination with other antiretrovirals. It may be used to prevent mothe ...

(brand name Retrovir and AZT) * Non-nucleoside reverse transcriptase inhibitors (NNRTIs): **

delavirdine Delavirdine (DLV) (brand name Rescriptor) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) marketed by ViiV Healthcare. It is used as part of highly active antiretroviral therapy (HAART) for the treatment of human immunodeficiency viru ...

(brand name Rescriptor, no longer available) * Attachment inhibitors ** fostemsavir (brand name Rukobia) * Integrase strand transfer inhibitors (INSTIs): ** dolutegravir (brand name Tivicay) **

cabotegravir Cabotegravir, sold under the brand name Vocabria among others, is an antiretroviral medication used for the treatment and prevention of HIV/AIDS. It is available in the form of tablets and as an intramuscular injection, as well as in an inject ...

(brand names Apretude PrEP">Pre-exposure_prophylaxis.html" ;"title="s a single agent indicated for PrEP and Cabenuva">Vocabria/Cabenuva [when co-administered with rilpivirine">Pre-exposure prophylaxis">PrEP and Cabenuva">Vocabria/Cabenuva [when co-administered with rilpivirine for HIV treatment – in partnership with Janssen Pharmaceuticals]) * Protease inhibitor (pharmacology), Protease inhibitors: ** fosamprenavir (brand names Lexiva and Telzir) ** nelfinavir (brand name Viracept) * Entry inhibitors: ** maraviroc (brand names Selzentry and Celsentri) * Antiretroviral fixed-dose combinations, including several single-pill regimens: ** abacavir/lamivudine (brand names Epzicom and Kivexa) ** abacavir/lamivudine/zidovudine (brand name Trizivir) ** lamivudine/zidovudine (brand name Combivir) ** abacavir/dolutegravir/lamivudine (brand name Triumeq) ** dolutegravir/lamivudine (brand name Dovato) ** dolutegravir/rilpivirine (brand name Juluca – in partnership with Janssen Pharmaceuticals)

Treatment access programs

ViiV Healthcare has stated that it will continue the not-for-profit pricing schemes that

and

GlaxoSmithKline GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British Multinational corporation, multinational Pharmaceutics, pharmaceutical and biotechnology company with headquarters in London. It was established in 2000 by a Mergers an ...

had been involved in prior to the setting up of the company. This program covers all low- and middle-income countries, as well as all of

Sub-Saharan Africa Sub-Saharan Africa is the area and regions of the continent of Africa that lie south of the Sahara. These include Central Africa, East Africa, Southern Africa, and West Africa. Geopolitically, in addition to the list of sovereign states and ...

."ViiV Healthcare Company Website. We Improve Access to Our Medicines"
Accessed 12 January 2014 The company has also granted voluntary licenses to 14 generics companies to enable the low-cost manufacture and sale of generic versions of the company's products in specific countries and/or regions. In March 2020, ViiV Healthcare announced the initiation of a study in partnership with

University of South Carolina The University of South Carolina (USC, SC, or Carolina) is a Public university, public research university in Columbia, South Carolina, United States. Founded in 1801 as South Carolina College, It is the flagship of the University of South Car ...

's Ryan White Program to determine the effectiveness of ride-sharing services in improving access to care for people living with HIV.

References

{{Authority control Pharmaceutical companies of the United Kingdom Pharmaceutical companies established in 2009 Joint ventures GSK plc Pfizer Life sciences industry Specialty drugs

Products

Treatment access programs

See also

References